Global Chronic Kidney Disease Markets and Technologies Through 2023

Ads

You May Also Like

Athenex, Inc. Announces Proposed Offering of Common Stock

BUFFALO, N.Y., Jan. 22, 2018 (GLOBE NEWSWIRE) -- Athenex (Nasdaq:ATNX), a global biopharmaceutical company ...

Immunocore strengthens IP position in the field of TCR-based therapeutics

PRESS RELEASE Immunocore strengthens IP position in the field of TCR-based therapeutics Notice of ...

Onconova Therapeutics, Inc. Reports Recent Business Highlights and Year-end 2015 Financial Results

NEWTOWN, Pa., March 28, 2016 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a clinical-stage ...